Yaffe MB et al. |
Priming of the neutrophil respiratory burst is species-dependent and involves MAP kinase activation. |
1999 |
Surgery |
pmid:10455891
|
Unno N et al. |
Single nucleotide polymorphism (G994-->T) in the plasma platelet-activating factor-acetylhydrolase gene is associated with graft patency of femoropopliteal bypass. |
2002 |
Surgery |
pmid:12110797
|
Takada Y et al. |
Prolonged hepatic warm ischemia in non-heart-beating donors: protective effects of FK506 and a platelet activating factor antagonist in porcine liver transplantation. |
1998 |
Surgery |
pmid:9626320
|
Porras-Reyes BH and Mustoe TA |
Platelet-activating factor: improvement in wound healing by a chemotactic factor. |
1992 |
Surgery |
pmid:1557687
|
Cuschieri J et al. |
Platelet-activating factor priming of inflammatory cell activity requires cellular adherence. |
2002 |
Surgery |
pmid:12219006
|
Liu T et al. |
Improved preservation of the rat liver for orthotopic liver transplantation: use of University of Wisconsin-lactobionate solution and retrograde reflushing. |
1990 |
Surgery |
pmid:2237771
|
Wang KS et al. |
Protective effect of platelet-activating factor antagonist on ischemia-induced liver injury in rats. |
1993 |
Surgery |
pmid:8417492
|
Fukuoka T et al. |
The platelet activating factor as a pivotal mediator of shock after liver ischemia. |
1995 |
Surg. Today |
pmid:7633127
|
Ono S et al. |
Clinical and experimental studies on the role of platelet-activating factor (PAF) in the pathogenesis of septic DIC. |
1993 |
Surg. Today |
pmid:8467174
|
Denham W and Norman J |
The potential role of therapeutic cytokine manipulation in acute pancreatitis. |
1999 |
Surg. Clin. North Am. |
pmid:10470326
|
Biffl WL et al. |
Neutrophil apoptosis is delayed by trauma patients' plasma via a mechanism involving proinflammatory phospholipids and protein kinase C. |
2001 |
Surg Infect (Larchmt) |
pmid:12593704
|
Anderson BO et al. |
The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure. |
1991 |
Surg Gynecol Obstet |
pmid:1851337
|
Wei Y et al. |
Structure of a microbial homologue of mammalian platelet-activating factor acetylhydrolases: Streptomyces exfoliatus lipase at 1.9 A resolution. |
1998 |
Structure |
pmid:9562561
|
Sirén AL et al. |
Increased release of tumor necrosis factor-alpha into the cerebrospinal fluid and peripheral circulation of aged rats. |
1993 |
Stroke |
pmid:8506560
|
Lindsberg PJ et al. |
Evidence for platelet-activating factor as a novel mediator in experimental stroke in rabbits. |
1990 |
Stroke |
pmid:2219210
|
Sirén AL et al. |
Release of proinflammatory and prothrombotic mediators in the brain and peripheral circulation in spontaneously hypertensive and normotensive Wistar-Kyoto rats. |
1992 |
Stroke |
pmid:1440713
|
Joseph R et al. |
Effect of therapy on platelet activating factor-induced aggregation in acute stroke. |
1989 |
Stroke |
pmid:2718200
|
Joseph R and Welch KM |
Granulocytes, platelet activating factor, and stroke. |
1989 |
Stroke |
pmid:2756548
|
Uhl E et al. |
Influence of platelet-activating factor on cerebral microcirculation in rats: part 1. Systemic application. |
1999 |
Stroke |
pmid:10187894
|
Uhl E et al. |
Influence of platelet-activating factor on cerebral microcirculation in rats: part 2. Local application. |
1999 |
Stroke |
pmid:10187895
|
Bielenberg GW et al. |
Infarct reduction by the platelet activating factor antagonist apafant in rats. |
1992 |
Stroke |
pmid:1731428
|
Joseph R et al. |
Effect of ticlopidine and aspirin on platelet ionized calcium in ischemic stroke. |
1991 |
Stroke |
pmid:2024285
|
Kochanek PM et al. |
Endogenous platelet activating factor does not modulate blood flow and metabolism in normal rat brain. |
1990 |
Stroke |
pmid:2309270
|
Feuerstein G et al. |
Platelet-activating factor. A putative mediator in central nervous system injury? |
1990 |
Stroke |
pmid:2237991
|
Yoshida H et al. |
Platelet-activating factor acetylhydrolase in red cell membranes. Does decreased activity impair erythrocyte deformability in ischemic stroke patients? |
1993 |
Stroke |
pmid:8418541
|
Nishida K and Markey SP |
Platelet-activating factor in brain regions after transient ischemia in gerbils. |
1996 |
Stroke |
pmid:8610322
|
Leont'ev VK and Kankanian AP |
[The local activation of leukocytes and thrombocytes in periodontal diseases: the role of thrombocyte-activating factor]. |
1996 |
Stomatologiia (Mosk) |
pmid:8658569
|
Liu J et al. |
New vernocuminosides from the stem barks of Vernonia cumingiana Benth. |
2009 |
Steroids |
pmid:18840454
|
Donnard M et al. |
Membrane and intracellular platelet-activating factor receptor expression in leukemic blasts of patients with acute myeloid and lymphoid leukemia. |
2002 |
Stem Cells |
pmid:12351810
|
Costa M et al. |
Derivation of endothelial cells from human embryonic stem cells in fully defined medium enables identification of lysophosphatidic acid and platelet activating factor as regulators of eNOS localization. |
2013 |
Stem Cell Res |
pmid:23164599
|
Wintroub BU and Soter NA |
Biology of the mast cell and its role in cutaneous inflammation. |
1981 |
Springer Semin. Immunopathol. |
pmid:7022722
|
Baltás E et al. |
Platelet-activating factor antagonist WEB 2086 inhibits ultraviolet-B radiation-induced dermatitis in the human skin. |
2003 Jul-Aug |
Skin Pharmacol. Appl. Skin Physiol. |
pmid:12784066
|
Glaser KB et al. |
Cellular and topical in vivo inflammatory murine models in the evaluation of inhibitors of phospholipase A2. |
1995 |
Skin Pharmacol. |
pmid:8688196
|
Kruse-Elliott KT et al. |
Role of lipid-derived mediators in tumor necrosis factor-induced endothelin-1 release in vivo. |
1998 |
Shock |
pmid:9466472
|
Kruse-Elliott KT et al. |
Low molecular weight heparin alters porcine neutrophil responses to platelet-activating factor. |
1998 |
Shock |
pmid:9744648
|
Cuschieri J et al. |
Calcium/calmodulin-dependent kinase II is required for platelet-activating factor priming. |
2005 |
Shock |
pmid:15665723
|
Rios-Santos F et al. |
A critical role of leukotriene B4 in neutrophil migration to infectious focus in cecal ligaton and puncture sepsis. |
2003 |
Shock |
pmid:12558146
|
Buripakdi D and Karlstad MD |
The role of platelet-activating factor in alterations of system A amino acid transport in rat soleus and extensor digitorum longus muscles during endotoxic shock. |
1994 |
Shock |
pmid:7735984
|
Enzan K et al. |
Thromboxane rather than platelet activating factor mediates pulmonary vasoconstriction after antigen challenge in rabbits. |
1996 |
Shock |
pmid:8885083
|
Koch T et al. |
Effects of stroma-free hemoglobin solutions on pulmonary vascular resistance and mediator release in the isolated perfused rabbit lung. |
1994 |
Shock |
pmid:7538430
|
Shouji K et al. |
Platelet-activating factor is a key mediator of pulmonary vasoconstriction and bronchoconstriction after antigen challenge in the perfused sensitized rabbit lung. |
1998 |
Shock |
pmid:9645492
|
Laniyonu AA et al. |
Endotoxin-induced microvascular leakage is prevented by a PAF antagonist and NO synthase inhibitor. |
1997 |
Shock |
pmid:8989836
|
Albert DH et al. |
ABT-299, a novel PAF antagonist, attenuates multiple effects of endotoxemia in conscious rats. |
1996 |
Shock |
pmid:8856845
|
Poeze M et al. |
Decreased organ failure in patients with severe SIRS and septic shock treated with the platelet-activating factor antagonist TCV-309: a prospective, multicenter, double-blind, randomized phase II trial. TCV-309 Septic Shock Study Group. |
2000 |
Shock |
pmid:11049104
|
Karlstad MD et al. |
Platelet-activating factor (PAF)-induced decreases in whole-body and skeletal muscle protein synthesis. |
2000 |
Shock |
pmid:11049115
|
James JH and Fischer JE |
Are the effects of platelet-activating factor on muscle metabolism of carbohydrates, amino acids and proteins attributable mainly to epinephrine? |
2000 |
Shock |
pmid:11049116
|
Ciesla DJ et al. |
Hypertonic saline inhibits neutrophil (PMN) priming via attenuation of p38 MAPK signaling. |
2000 |
Shock |
pmid:11028541
|
Klabunde RE and Calvello C |
Inhibition of endotoxin-induced microvascular leakage by a platelet-activating factor antagonist and 5-lipoxygenase inhibitor. |
1995 |
Shock |
pmid:8595525
|
Cureton EL et al. |
Endothelin 1 and prostacyclin attenuate increases in hydraulic permeability caused by platelet-activating factor in rats. |
2010 |
Shock |
pmid:19940814
|
Mariano F et al. |
Platelet-activating factor synthesis by neutrophils, monocytes, and endothelial cells is modulated by nitric oxide production. |
2003 |
Shock |
pmid:12688545
|